Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Astellas Pharma Global Development, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects

Phase 1

Completed

Conditions: Bioavailability of ASP015K
Healthy Subjects
Pharmacokinetics of ASP015K
Food Effect of ASP015K

Interventions: Drug: ASP015K

First Posted Date: 2013-08-28

Last Posted Date: 2013-09-16

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 36

Registration Number: NCT01929577

Locations: 🇺🇸
Parexel - Early Phase Clinical Unit, Baltimore, Maryland, United States

Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Regadenoson
Drug: Placebo

First Posted Date: 2013-08-08

Last Posted Date: 2013-08-30

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 36

Registration Number: NCT01918995

Locations: 🇺🇸
Parexel Early Phase Unit, Baltimore, Maryland, United States

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of Metformin
Healthy Subjects

Interventions: Drug: isavuconazole
Drug: metformin

First Posted Date: 2013-06-24

Last Posted Date: 2013-06-24

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01884558

Locations: 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of Methotrexate
Pharmacokinetics of 7-hydroxymethotrexate
Healthy Subjects

Interventions: Drug: isavuconazole
Drug: methotrexate

First Posted Date: 2013-06-24

Last Posted Date: 2013-06-24

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01884636

Locations: 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Phase 3

Completed

Conditions: Cytomegalovirus (CMV)-Positive Recipients
Allogeneic, Hematopoietic Cell Transplant (HCT)

Interventions: Biological: ASP0113
Drug: Placebo

First Posted Date: 2013-06-14

Last Posted Date: 2024-10-24

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 514

Registration Number: NCT01877655

Locations: 🇺🇸
Site US10028, Birmingham, Alabama, United States
🇺🇸
Site US10044, Tucson, Arizona, United States
🇺🇸
Site US10035, San Francisco, California, United States

and more 80 locations

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

Phase 1

Completed

Conditions: Pharmacokinetics of Fidaxomicin
Healthy Subjects

Interventions: Drug: Placebo
Drug: Fidaxomicin

First Posted Date: 2013-03-19

Last Posted Date: 2014-05-21

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 36

Registration Number: NCT01813448

Locations: 🇺🇸
Parexel, Glendale, California, United States

Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects

Phase 1

Completed

Conditions: Pharmacokinetics of 14C-labeled Isavuconazole
Healthy Subjects

Interventions: Drug: 14C-labeled prodrug isavuconazonium sulfate

First Posted Date: 2013-03-19

Last Posted Date: 2013-03-19

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 8

Registration Number: NCT01813461

Locations: 🇺🇸
Covance, Madison, Wisconsin, United States

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Sirolimus

Interventions: Drug: isavuconazole
Drug: sirolimus

First Posted Date: 2013-03-13

Last Posted Date: 2013-03-13

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 22

Registration Number: NCT01809860

Locations: 🇺🇸
Covance, Dallas, Texas, United States

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Phase 2

Completed

Conditions: Kidney Transplantation

Interventions: Drug: ASKP1240
Drug: Tacrolimus
Drug: Mycophenolate Mofetil (MMF)
Drug: Basiliximab
Drug: Methylprednisone
Drug: Prednisone

First Posted Date: 2013-01-31

Last Posted Date: 2024-01-08

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 149

Registration Number: NCT01780844

Locations: 🇺🇸
Site US10006, Birmingham, Alabama, United States
🇺🇸
Site US10024, Phoenix, Arizona, United States
🇺🇸
Site US10008, Los Angeles, California, United States

and more 39 locations

A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

Phase 2

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: peficitinib

First Posted Date: 2012-10-22

Last Posted Date: 2024-10-21

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 611

Registration Number: NCT01711814

Locations: 🇺🇸
Site US3218, Birmingham, Alabama, United States
🇺🇸
Site US828, La Jolla, California, United States
🇺🇸
Site US3227, Palm Desert, California, United States

and more 48 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy